Diazepam effects on anxiety-related defensive behavior of male and female high and low open-field activity inbred mouse strains.

Anxiety Anxiolytic Diazepam Elevated plus-maze Fear Open-field test

Journal

Physiology & behavior
ISSN: 1873-507X
Titre abrégé: Physiol Behav
Pays: United States
ID NLM: 0151504

Informations de publication

Date de publication:
01 Nov 2023
Historique:
received: 04 05 2023
revised: 26 08 2023
accepted: 06 09 2023
pubmed: 10 9 2023
medline: 10 9 2023
entrez: 9 9 2023
Statut: ppublish

Résumé

Open-field activity is a commonly used measure of anxiety-related behavior in rodents. The inbred High and Low Activity strains of mice, selected for extreme differences in open-field activity, have been used as a genetic model of anxiety-related behaviors. These selected strains have been thoroughly studied through extensive behavioral testing, quantitative trait locus (QTL) mapping, whole-genome sequencing, and RNA sequencing, to uncover phenotypic and genotypic differences related to anxiety-related behavior. However, the effects of anxiolytic drugs on anxiety-related behavior in these strains have not been studied previously. This study allowed us to expand on previous findings to further characterize the anxiety-related behavior of these unique strains, using an anxiolytic drug. The goal of this study was to determine whether the treatment of adult male and female High Activity (low anxiety) and Low Activity (high anxiety) mice with diazepam, an agonist at the benzodiazepine allosteric site on the GABA

Identifiants

pubmed: 37689380
pii: S0031-9384(23)00268-8
doi: 10.1016/j.physbeh.2023.114343
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114343

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing interests.

Auteurs

Erika A Mehrhoff (EA)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States; Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, United States.

Winona C Booher (WC)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States; Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, United States; Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.

Julianna Hutchinson (J)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.

Grace Schumacher (G)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.

Curtis Borski (C)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States; Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, United States.

Christopher A Lowry (CA)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States.

Charles A Hoeffer (CA)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States; Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, United States.

Marissa A Ehringer (MA)

Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, United States; Institute for Behavioral Genetics, University of Colorado Boulder, Boulder, Colorado, United States. Electronic address: marissa.ehringer@colorado.edu.

Classifications MeSH